CFDE Workbench
Information PortalData PortalKnowledge Portal
Search
Graph
Enrichment
Cross
Assistant
Data Matrix
Use Cases
Tools & Workflows
Submit
Documentation
CFDE Workbench

Hepatitis C, Chronic (Disease Or Phenotype)

Nci:C197873
Msh:D019698
Mondo:MONDO:5354
Medcin:MEDCIN:38272
Mdr:MDR:10008912
Id:39ba23d3-4957-5b9b-bc47-fade40f432fb
Icpc2icd10eng:MTHU034339
Icd10cm:B18.2
Efo:EFO:4220
Chv:CHV:38367
Results found

Linked to

 

Label

Description

 

Knowledge Graph Assertion

Uridine, 2'-deoxy-2'-fluoro-2'-methyl-, (2'R)- indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Vaniprevir indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Voxilaprevir indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Pibrentasvir indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Ombitasvir indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Cycloprop(d)indolo(2,1-a)(2)benzazepine-9-carboxamide, 12-cyclohexyl-N-((dimethylamino)sulfonyl)-4b,5,5a,6-tetrahydro-3-methoxy-5a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)-, (4bS,5aR)- indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Velpatasvir indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Paritaprevir indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

sodium;diiodomethanesulfonate;N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Uridine, 2'-deoxy-2'-fluoro-2'-methyl-, (2'R)- indication Hepatitis C, Chronic

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Vaniprevir indication Hepatitis C, Chronic

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Voxilaprevir indication Hepatitis C, Chronic

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Pibrentasvir indication Hepatitis C, Chronic

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Ombitasvir indication Hepatitis C, Chronic

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Cycloprop(d)indolo(2,1-a)(2)benzazepine-9-carboxamide, 12-cyclohexyl-N-((dimethylamino)sulfonyl)-4b,5,5a,6-tetrahydro-3-methoxy-5a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)-, (4bS,5aR)- indication Hepatitis C, Chronic

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    (1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide indication Hepatitis C, Chronic

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Velpatasvir indication Hepatitis C, Chronic

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Paritaprevir indication Hepatitis C, Chronic

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    sodium;diiodomethanesulfonate;N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide indication Hepatitis C, Chronic

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2025
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2025
    This repository is under review for potential modification in compliance with Administration directives.